Skip to main content

. 1977 Jun 25;1(6077):1638–1639. doi: 10.1136/bmj.1.6077.1638

Megaloblastic anaemia associated with sulphasalazine treatment.

R E Schneider, L Beeley

PMCID: PMC1607743 PMID: 17446

1638

Images in this article

FIG 1
on p.1639

FIG 2
on p.1639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Collins J. R. Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis. South Med J. 1968 Apr;61(4):354–358. doi: 10.1097/00007611-196804000-00005. [DOI] [PubMed] [Google Scholar]
Franklin J. L., Rosenberg H. H. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine). Gastroenterology. 1973 Apr;64(4):517–525. [PubMed] [Google Scholar]
Juhl R. P., Summers R. W., Guillory J. K., Blaug S. M., Cheng F. H., Brown D. D. Effect of sulfasalazine on digoxin bioavailability. Clin Pharmacol Ther. 1976 Oct;20(4):387–394. doi: 10.1002/cpt1976204387. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES